Drug Topics
MAY 12, 2023
Listen to the first episode of RPHCast, where Kevin and Donna educate you on all things statins, blood pressure, cholesterol, and as many curves as you can imagine.
IDStewardship
MAY 12, 2023
In this article five tips for incoming PGY2 pharmacy residents is provided. Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article posted: 12 May 2023 The ASHP pharmacy residency match phases 1 and 2 have come to a close. Pharmacy residents are headed for their second year of training and are now lined up to land at the (likely) final destination in their training journey.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MAY 12, 2023
Research shows that patient experiences and sometimes outcomes are improved when they are treated by health care professions from similar communities.
Pharmacy Times
MAY 12, 2023
BI 456906 activates the GLP-1 and glucagon receptors that help to control metabolic function, and could potentially offer clinically relevant benefits for those living with obesity or overweight without type 2 diabetes.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
MAY 12, 2023
Sometimes, paid advertising isn’t the best way to get the word out.
Pharmacy Times
MAY 12, 2023
Investigators found that providing parents with a hypothetical scenario outlining why they should immunize their children against COVID-19 was effective in improving vaccination rates.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
MAY 12, 2023
With a growing expectation for individualized and personalized care, medically integrated pharmacies have a great opportunity to support patients and the care team.
Drug Topics
MAY 12, 2023
Juliana Reed, executive director of the Biosimilars Forum, discussed the impact of market dynamics and changing pricing structures during a presentation at the 2023 Asembia Specialty Pharmacy Summit.
Pharmacy Times
MAY 12, 2023
A new FDA policy would assess blood donor eligibility using a set of individual risk-based questions to reduce the risk of transfusion-transmitted HIV.
Drug Topics
MAY 12, 2023
Parcel tracking technology that used predictive analytics can help with real-time package delivery monitoring and ensure on-time delivery.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
MAY 12, 2023
Brexpiprazole was associated with a statistically and clinically meaningful improvement in agitative behaviors caused by dementia compared to placebo.
STAT
MAY 12, 2023
The Food and Drug Administration is convening a meeting of outside experts on Friday to review clinical data on an experimental gene therapy for Duchenne muscular dystrophy from Sarepta Therapeutics. The stakes for this all-day meeting are high and deliberations could be contentious. The advisory panel meeting is one of the most pivotal moments in recent memory for Duchenne patients and their families, many of whom view Sarepta’s gene therapy as the best hope for slowing the fatal muscle-
Drug Store News
MAY 12, 2023
Timed with the formal end of the COVID-19 public health emergency on May 11, an NACDS ad is punctuating the occasion with a “thank you” to pharmacists and pharmacy teams.
STAT
MAY 12, 2023
Brain cancer patients are left with few options when tumor cells spread, as most potent chemotherapies are unable to cross the blood-brain barrier. But a study published last week in the Lancet offers some hope: an ultrasound device implanted in 17 patients’ skulls successfully increased the concentration of drugs in their brains. It’s the first, in-human trial of the novel device, which is manufactured by French device maker Carthera.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Topics
MAY 12, 2023
Discussions around women’s health should extend beyond talking about menstruation and pregnancy to include all aspects of health.
European Pharmaceutical Review
MAY 12, 2023
Swedish Orphan Biovitrum AB (Sobi ® ) has agreed to acquire CTI BioPharma for $1.7 billion, with the intention to advance an oral kinase inhibitor treatment for the rare disease myelofibrosis. Innovative therapies for rare diseases The acquisition will help to drive the growth of CTI’s lead product, kinase inhibitor VONJO ® (pacritinib) “in treating myeloproliferative disease,” stated Dr Adam Craig, President, Chief Executive Officer and Interim Chief Medical Officer of CTI BioPharma
STAT
MAY 12, 2023
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Pharmacy Times
MAY 12, 2023
Nonprescription products manage mild to moderate symptoms, but more severe cases need further medical evaluation.
STAT
MAY 12, 2023
As a child, I fondly remember running through the kids’ aisle at Video World with my younger brother. We were excited to pick out VHS tapes for our family to watch over the weekend. I don’t recall whether this was every weekend or once a month, but movie nights were frequent enough that they made up for my parents’ repeated absences in those years.
Pharmaceutical Technology
MAY 12, 2023
The Technical University of Denmark (DTU) has announced that an international scientific team has developed a CRISPR-based drug candidate that targets E coli directly and leaves the microbiome intact. Blood cancer patients with E coli infection are at risk of bacteria infecting the bloodstream. An E coli infection can be fatal in these cases, with a 15-20% mortality rate.
STAT
MAY 12, 2023
For an archived version of a live blog about Friday’s FDA advisory panel hearing, click here. A panel of independent advisers to the Food and Drug Administration narrowly voted 8-6 to recommend accelerated approval for Sarepta’s gene therapy for Duchenne muscular dystrophy , ruling that the potential benefit to patients outweighs a long list of concerns from the agency’s reviewers.
Pharmaceutical Technology
MAY 12, 2023
Takeda has reported a 12.8% increase in its reported revenue to $29.96bn (Y4,027bn) during the fiscal year 2022 (FY2022) compared to that reported in FY2021. At a constant exchange rate (CER), the company’s core revenue grew by 3.5% compared to the previous year. In the FY2022 ending 31 March 2023, the company also reported a 6.4% rise in its operating profit to $3.65bn (Y490.5bn) compared to 2021.
STAT
MAY 12, 2023
When the Supreme Court overturned Roe v. Wade , it effectively rescinded national protections of reproductive health care. The decision was very quickly followed by abortion bans in 14 states with more pending such as the highly restrictive 12-week abortion ban recently passed by North Carolina. The tragic results are already too numerous to name here.
Pharmaceutical Technology
MAY 12, 2023
Editas Medicine will release new efficacy and safety results of its gene therapy EDIT-301 in severe sickle disease as part of an oral presentation at the European Hematology Association’s (EHA) Hybrid Congress. The EHA Hybrid Congress will take place on June 8-11 in Frankfurt, Germany. Last month, the US Food and Drug Administration (FDA) granted the treatment an orphan drug designation for sickle cell disease.
Pharmacy Times
MAY 12, 2023
Atogepant reduced mean monthly migraine days by more than 2 days compared to placebo in the ELEVATE trial.
STAT
MAY 12, 2023
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda will focus largely on Mrs. Pharmalot as she turns another page on the calendar and also on fostering a potential mascot — wish us luck. And of course, we hope to squeeze in another listening party.
PharmExec
MAY 12, 2023
Stefan Merlo, Vice President, Commercial Development, CSL Seqirus discusses how COVID-19 has evolved the discussion of vaccines and the long-term concerns stemming from flu vaccine fatigue.
Drug Topics
MAY 12, 2023
Vasomotor symptoms include hot flashes and night sweats, which can negatively impact a woman's quality of life.
Fierce Pharma
MAY 12, 2023
As pharma fights IRA, Senate moves forward basket of bills aimed at lower drug prices aliu Fri, 05/12/2023 - 10:48
European Pharmaceutical Review
MAY 12, 2023
A BioNTech-led Phase I trial demonstrated preliminary evidence that adjuvant autogene cevumeran, a personalised mRNA neoantigen vaccine, in combination with atezolizumab (Genentech) and mFOLFIRINOX can induce substantial T cell activity in pancreatic ductal adenocarcinoma (PDAC). In a paper published in Nature , researchers hypothesised it may correlate with delayed recurrence and elimination of micrometastases in PDAC.
Drug Store News
MAY 12, 2023
Patients may have symptoms for a long time before seeking medical attention or receiving a colon cancer diagnosis, which is treatable if discovered early.
Fierce Healthcare
MAY 12, 2023
Million-dollar claims on the rise in self-insured employer plans: report fdiamond Fri, 05/12/2023 - 15:45
Drug Topics
MAY 12, 2023
88% of surveyed payers said interchangeability will have the biggest impact on adoption.
Drug Store News
MAY 12, 2023
New launches include milk chocolate dipped cranberry bites and dark chocolate dipped cherry-infused cranberry bites.
Expert insights. Personalized for you.
187 
Let's personalize your content